-
In this study, a European consortium of investigators evaluated the ability of an automatic external cardioverter defibrillator (AECD) to detect and treat arrhythmias in the in-hospital setting.
-
Cardiac resynchronization reduces the mortality of progressive heart failure in patients with symptomatic left ventricular dysfunction and dyssynchrony.
-
Rheumatoid arthritis should be recognized as a marker of increased risk for myocardial infarction.
-
Although fibrinolytic therapy was highly successful for thrombosis of prosthetic mechanical heart valves, a high complication rate limits its use to nonsurgical candidates.
-
While the clinical benefit of oral N-acetylcysteine on reducing rates of contrast nephropathy for a given patient is unproven, it should be considered for all patients with abnormal renal function referred for elective coronary angiography.
-
In patients with active lymphocytic myocarditis and persistent heart failure for greater than 6 months, those with circulating cardiac autoantibodies and no viral genomes detected on myocardial biopsy are the most likely to benefit from immunosuppressive therapy.
-
Low intensity warfarin therapy effectively prevents recurrent venous thromboembolism, according to a recent study in the New England Journal of Medicine.
-
-
The trial concluded that platinum-based adjuvant chemotherapy improved overall survival and recurrence-free survival at 5 years in this combined group of patients with early stage ovarian cancer defined by the inclusion criteria of the ICON1 and ACTION trials.
-
In postmenopausal patients with sexual dysfunction, it is still unclear which, if any, therapy is indicated.
